Evidence map›Paper›PMID 41814324›Full record

ArticleJournal of inflammation (London, England)2026

Activated platelets promote endothelial dysfunction and monocyte recruitment in early renal microvascular injury.

Ukhti Jamil Rustiasari, Melissa Uil, Xiaomeng Zhang, Nike Claessen, Loes Butter, Anne-Marieke D van Stalborch, Sandrine Florquin, Jaap D van Buul, Alessandra Tammaro, Joris J T H Roelofs

Abstract read
In one paragraph

Article in Journal of inflammation (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ukhti Jamil RustiasariDepartment of Pathology, Amsterdam UMC Location University of Amsterdam, Amsterdam, The Netherlands.
Melissa UilDepartment of Pathology, Amsterdam UMC Location University of Amsterdam, Amsterdam, The Netherlands.
Xiaomeng ZhangDepartment of Pathology, Amsterdam UMC Location University of Amsterdam, Amsterdam, The Netherlands.
Nike ClaessenDepartment of Pathology, Amsterdam UMC Location University of Amsterdam, Amsterdam, The Netherlands.
Loes ButterDepartment of Pathology, Amsterdam UMC Location University of Amsterdam, Amsterdam, The Netherlands.
Anne-Marieke D van StalborchVascular Biology Lab, Medical Biochemistry Department at Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Sandrine FlorquinDepartment of Pathology, Amsterdam UMC Location University of Amsterdam, Amsterdam, The Netherlands.
Jaap D van BuulVascular Biology Lab, Medical Biochemistry Department at Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Alessandra Tammaro *Department of Pathology, Amsterdam UMC Location University of Amsterdam, Amsterdam, The Netherlands. a.tammaro@amsterdamumc.nl.
Joris J T H Roelofs *Department of Pathology, Amsterdam UMC Location University of Amsterdam, Amsterdam, The Netherlands. j.j.roelofs@amsterdamumc.nl.

Funding

the Netherlands Organization for Health Research and Development ZonMw, grant no. 40-00703-97-12480
6 · The paper itself

Abstract

Chronic kidney disease (CKD) is characterized not only by progressive fibrosis but also by systemic endothelial dysfunction and inflammation. Platelets, traditionally recognized for their role in hemostasis, also serve as key modulators of endothelial activation and immune cell recruitment. Platelet activation is commonly observed in patients with CKD and contributes to the proinflammatory environment. Although platelet-endothelial interactions are well-characterized in cardiovascular disease, their role in renal endothelial dysfunction and inflammation remains poorly understood. To investigate this, we used the unilateral ureteral obstruction (UUO) model in mice, to examine how platelet activation influences endothelial responses and monocyte/macrophage recruitment in the early phase of renal fibrosis development. Platelet depletion reduced the number of infiltrating macrophages in kidney tissue, decreased expression of endothelial activation and inflammation markers, and preserved the peritubular capillary (PTC) integrity. Further in vitro studies using human umbilical vein endothelial cells (HUVECs) showed that activated platelets induced endothelial dysfunction and inflammation, in line with the in vivo findings. To recapitulate the vascular microenvironment, we performed a shear flow-based transmigration assay. Monocyte adhesion and transendothelial migration significantly increased when endothelial cells were pretreated with activated platelets compared to unstimulated controls. Moreover, the presence of platelets on the inflamed endothelium further enhanced monocyte migration, suggesting a synergistic effect in promoting immune cell recruitment. Collectively, our findings highlight that activated platelets contribute to endothelial dysfunction, inflammation, and monocyte infiltration in early kidney injury, suggesting their potential as a therapeutic target to mitigate microvascular injury and preserve renal vascular integrity in kidney disease.

Indexed as

Chronic kidney diseaseEndothelial dysfunctionMonocytes recruitmentPlatelet activationPlatelet-endothelial interaction

Identifiers

PMID41814324
PMCPMC13088686

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.